Ricky Mulvey and Motley Fool analyst Kirsten Gura dive into a biotech company that owns a virtual monopoly for a life-changing treatment. You can't innovate and generate solid free cash flow without innovating, they say. How do you think about regulatory risk in vertic Pharmaceuticals? We'll have to wait and see what happens with this one.
A former Samsung executive allegedly stole plans in order to build a chip plant down the road from the existing factory. What could possibly go wrong?
(00:15) Bill Mann and Deidre Woollard discuss:
- The high value of getting a leg up on the competition in the semiconductor industry.
- If companies can do anything to keep secrets from leaking out.
- Why Alphabet’s adtech is attracting regulators’ attention.
(13:53) Ricky Mulvey and Kirsten Guerra take a look at Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment.
Companies discussed: GOOG, GOOGL,KO, VRTX, SSNLFHost: Deidre Woollard
Guests: Bill Mann, Ricky Mulvey, Kirsten Guerra Producer: Ricky Mulvey Engineer: Tim Sparks
Learn more about your ad choices. Visit megaphone.fm/adchoices